先看重点
一项纳入6项研究、223名肌少症老年人的荟萃分析发现,全身振动(SMD 0.69,95%置信区间0.28至1.11,P = 0.001)和局部振动(SMD 3.78,95%置信区间2.29至5.28,P < 0.001)均提高了肌肉力量。作者提醒,纳入研究数量有限,需谨慎解读。
证据类型
证据综述
解读依据
公开摘要
阅读重点
方法与适用范围
研究在问什么
许多虚弱的老年人无法进行高强度运动,而振动疗法风险低、容易参与。作者检验局部或全身振动能否改善肌少症老年人的肌肉量、肌肉力量和身体功能。
研究了谁,如何研究
系统评价和荟萃分析。2019年3月检索PubMed、CINAHL、Embase、PEDro和Cochrane中央对照试验注册库五个数据库,不限语言和年份。纳入肌少症老年人的随机对照试验和准实验研究,由两名评价者独立评估方法学质量。检索到1972项研究,最终纳入来自6项研究的7篇文献、223名参与者,其中5项为全身振动,2项为局部振动。
主要发现
以下为作者报告的结果。数字须连同人群和不确定性一起阅读。
- 1全身振动后肌肉力量增加(SMD 0.69,95%置信区间0.28至1.11,I2 = 0%,P = 0.001)。
- 2局部振动后肌肉力量同样增加(SMD 3.78,95%置信区间2.29至5.28,P < 0.001),但这一异常大的估计只来自很少的研究。
- 3身体表现改善:起坐试验(SMD -0.79,95%置信区间-1.21至-0.37,I2 = 0%,P < 0.001)和计时起立行走试验(SMD -0.83,95%置信区间-1.56至-0.11,I2 = 64%,P = 0.02)。
局限与不确定性
- 1仅纳入6项研究、223名参与者,合并估计的基础较小。
- 2摘要没有报告肌肉量的结果,因此无法从中得知振动是否改变肌肉大小。
- 3纳入了准实验设计和随机对照试验,计时起立行走结果的异质性为中度到较高(I2 = 64%)。以上解读仅基于摘要。
对日常健康的启示
对无法进行高强度运动的老年人,振动疗法可能是支持力量和活动能力的温和选择,但证据还很初步。它不能替代日常活动和抗阻训练,想尝试的人应先咨询医生,尤其是有基础疾病者。
如何联系自己的数据
可穿戴设备不会记录振动治疗,但可以记录本研究关心的结果:起坐次数、步行速度或计时起立行走的时间,以及步数趋势。请用同样的方式、在相近的时间测试,看数周内的变化。
如何理解这类证据
先看纳入了哪些设计、检索与偏倚评估如何完成,以及检索截止日期;发表新不代表底层证据都是最新的。
作者的结构化摘要 English
以下英文摘要按记录的开放许可转载,属于作者原始材料,不是 MoveVitals 的解读。上方已提供研究解读,分别说明作者结果与本站解释;重要结论可直接核对原文。
Background
Sarcopenia, a progressive loss of muscle mass and function with advancing age, is a prevalent condition among older adults. As most older people are too frail to do intensive exercise and vibration therapy has low risk and ease of participation, it may be more readily accepted by elderly individuals. However, it remains unclear whether vibration therapy would be effective among older adults with sarcopenia. This systematic review and meta-analysis examined the effect of vibration therapy including local vibration therapy and whole-body vibration therapy, for enhancing muscle mass, muscle strength and physical function in older people with sarcopenia.
Methods
A systematic literature search was conducted in March 2019 in the following 5 electronic databases: PubMed, CINAHL, Embase, PEDro, and the Cochrane Central Register of Controlled Trials, with no restriction of language or the year of publication. Randomized controlled trials and quasi-experimental studies examining effects of vibration therapy on muscle mass, muscle strength or physical function in older adults with sarcopenia were included in this systematic review. Two reviewers independently assessed the methodological quality of the selected studies.
Results
Of the 1972 identified studies, seven publications from six studies involving 223 participants were included in this systematic review. Five of them conducted whole-body vibration therapy, while two conducted local vibration therapy. A meta-analysis of randomized controlled studies indicated that muscle strength significantly increased after whole-body vibration therapy (SMD 0.69, 95% CI 0.28 to 1.11, I^(2) = 0%, P = 0.001) and local vibration therapy (SMD 3.78, 95% CI 2.29 to 5.28, P < 0.001). Physical performance measured by the sit-to-stand test and the timed-up-and-go test were significantly improved after the intervention (SMD -0.79, 95% CI - 1.21 to - 0.37, I^(2) = 0%, P < 0.001) and SMD -0.83, 95% CI - 1.56 to - 0.11, I^(2) = 64%, P = 0.02, respectively).
Conclusion
Vibration therapy could be a prospective strategy for improving muscle strength and physical performance in older adults with sarcopenia. However, due to the limited number of the included studies, caution is needed when interpreting these results. More well-designed, large sample size studies should be conducted to further explore and validate the benefits of vibration therapy for this population.
来源与署名
Effects of vibration therapy on muscle mass, muscle strength and physical function in older adults with sarcopenia: a systematic review and meta-analysis.
Wu S, Ning HT, Xiao SM, Hu MY, Wu XY, Deng HW, Feng H.
European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2020-09-17
DOI: 10.1186/s11556-020-00247-5 ↗PubMed · 32963629 ↗Europe PMC · 记录的开放许可: cc by ↗摘要版权归原作者,依据来源记录的开放许可转载。中文译文辅助阅读,英文摘要用于核对术语与具体数值;本站的方法学解释与作者结论分别呈现。
MoveVitals 编辑解读 · 健康教育内容 · 未记录个人临床审阅
来源核验日期 2026-11-01
实用健康指南
放在一起读
ACSM综述137项系统评价:抗阻训练有效,影响结果的方案细节很少
美国运动医学会汇总了137项系统评价(超过30,000名健康成年人),认为抗阻训练在力量、肌肉量、爆发力、耐力和多项功能测试上优于不运动。能一致影响结果的方案细节很少:较大负荷(不低于单次最大重复量的80%)和2至3组有利于力量,每周至少10组有利于肌肉量,而训练至力竭、器械类型和周期化则没有一致影响。它汇总的是系统评价而非新试验,没有合并效应量,所依据的多为未经训练者,且各评价所含的原始试验有重叠。
Medicine & Science in Sports & Exercise
几乎所有抗阻训练方案都优于不运动,大负荷在力量上排名居前
一项纳入随机试验的网状荟萃分析(力量网络178项研究、5097人,肌肥大网络119项研究、3364人)显示,几乎所有抗阻训练方案都优于不运动。大负荷、多组、每周至少3次的方案在力量上排名最前(标准化均数差1.60,95%可信区间1.38至1.82),大负荷、多组、每周2次的方案在肌肥大上排名最前(0.66,0.47至0.85)。多数方案之间在统计学上无法区分(91%的两两比较中95%可信区间包含零),且偏倚风险为中到高,因此排名只是初步参考。
British Journal of Sports Medicine
肌肉强化活动与更低的死亡、心血管病、癌症和糖尿病风险相关
汇总16项成年人前瞻性队列研究,进行肌肉强化活动者的全因死亡风险低15%(RR 0.85,95%置信区间0.79至0.93),心血管疾病和糖尿病风险各低17%(RR均为0.83)。全因死亡曲线在每周约40分钟时最低(RR 0.83),但更大运动量是有益还是有害尚不清楚。这些都是观察性结果,主要来自美国的自我报告数据,作者将大多数结局的证据确定性评为极低。
British Journal of Sports Medicine
蛋白补充剂配合力量训练:额外增益有限,年长者更少
汇总49项随机对照试验、1863名进行至少6周抗阻训练的健康成年人,蛋白补充剂在单纯训练的基础上使去脂体重多增加0.30 kg(95%置信区间0.09至0.52),使最大重复量力量多增加2.49 kg(0.64至4.33)。这些增量远小于训练本身的作用,年龄越大越弱,而所谓1.6 g/kg/天的平台点没有统计学意义(P=0.079)。有一位作者曾获美国国家乳制品委员会资助,该机构也资助过纳入分析的试验。
British Journal of Sports Medicine

